STOCK TITAN

Neurocrine Biosciences to Present at the Citi 15th Annual BioPharma Virtual Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Neurocrine Biosciences (Nasdaq: NBIX) will present at the Citi 15th Annual BioPharma Virtual Conference on September 9, 2020, at 12:35 p.m. ET. CEO Kevin Gorman will deliver the presentation, which will be available via a live webcast on the company's website. A replay of the presentation will be accessible approximately one hour after the event, remaining archived for about a month. Neurocrine is focused on developing treatments for neurological and psychiatric disorders, with several FDA-approved products and ongoing clinical programs.

Positive
  • None.
Negative
  • None.

SAN DIEGO, Sept. 2, 2020 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the Citi 15th Annual BioPharma Virtual Conference at 12:35 p.m. ET on Wednesday, September 9, 2020. Kevin Gorman, Chief Executive Officer, will present at the conference.

The live presentation will be webcast and may be accessed on the Company's website under Investors at www.neurocrine.com. A replay of the presentation will be available on the website approximately one hour after the conclusion of the event and will be archived for approximately one month.

About Neurocrine Biosciences
Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company with 28 years of experience discovering and developing life-changing treatments for people with serious, challenging and under-addressed neurological, endocrine and psychiatric disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, Parkinson's disease, endometriosis* and uterine fibroids*, with three pivotal and five mid-stage clinical programs in multiple therapeutic areas. Headquartered in San Diego, Neurocrine Biosciences specializes in targeting and interrupting disease-causing mechanisms involving the interconnected pathways of the nervous and endocrine systems. For more information, visit neurocrine.com, and follow the company on LinkedIn(*in collaboration with AbbVie)

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/neurocrine-biosciences-to-present-at-the-citi-15th-annual-biopharma-virtual-conference-301123291.html

SOURCE Neurocrine Biosciences, Inc.

FAQ

When will Neurocrine Biosciences present at the Citi BioPharma Virtual Conference?

Neurocrine Biosciences will present on September 9, 2020, at 12:35 p.m. ET.

Who will present at the Citi BioPharma Virtual Conference for Neurocrine Biosciences?

CEO Kevin Gorman will present for Neurocrine Biosciences.

Where can I watch the Neurocrine Biosciences presentation live?

The presentation can be accessed live on the Neurocrine Biosciences website.

Will there be a replay of the Neurocrine Biosciences presentation?

Yes, a replay will be available about one hour after the conclusion of the presentation.

What is the stock symbol for Neurocrine Biosciences?

The stock symbol for Neurocrine Biosciences is NBIX.

Neurocrine Biosciences Inc

NASDAQ:NBIX

NBIX Rankings

NBIX Latest News

NBIX Stock Data

12.65B
99.72M
0.99%
95.59%
2.45%
Drug Manufacturers - Specialty & Generic
Biological Products, (no Disgnostic Substances)
Link
United States of America
SAN DIEGO